Searched for
ROCHE GROUP
Indian companies announce $1.1 billion investment in US, to create 1,500 jobsTwelve Indian companies announced over USD 1.1 billion in US investments across aerospace, defense, energy, and AI sectors at the SelectUSA...- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Roche ramps up AI computing capacity with Nvidia chip expansionRoche said the additional hardware would speed up work across its research and development operations, including modelling, data analysis...
- Natco wins patent battle to launch generic 'Risdiplam'A Delhi High Court ruling favors Natco Pharma against Roche's rare disease drug. Natco can now launch generic risdiplam, used for spinal mu...
- Roche Diagnostics appoints Narendra Varde as MD India & Neighbouring MarketsRoche Diagnostics India, a part of the Roche Group, on Wednesday announced the appointment of Narendra Varde as Managing Director for India...
- Swiss pharma company Roche faces probe for blocking cheaper cancer drugsThe probe has been ordered in response to a complaint filed by Bengaluru-based Biocon and US firm Mylan, who together sell biosimilars of t...
- CCI to investigate Swiss drugmaker Roche over breast cancer biosimilarCCI’s action is in response to a complaint filed by Mylan and Biocon, who have together developed biosimilar version of Roche’s blockbuster...
- CCI orders detailed probe against pharma major RocheAccording to the CIC, Roche Group is dominant in the relevant market and can operate independently of the market forces.
- Biotech giant Roche takes NPPA to court over cap on injection priceOn May 9, the NPPA issued a notification capping the price of trastuzumab 440mg/50ml injections at Rs 55,812.29 per pack.
- Roche launches new breast cancer drugs in IndiaRoche Products (India) Private Ltd is a wholly owned subsidiary of the Switzerland based Roche Group and has products in therapeutic areas .
- Health groups lash out at HC order baning Biocon, Mylan from selling biosimilar breast cancer drugPublic health groups lashed out at High Court order that stopped Biocon, Mylan from selling biosimilar versions of breast cancer drug Herce...
- Biocon ups generic war with nod for Roche's cancer drug cloneBiocon officials confirmed the development to ET but didn't shed light on how soon the company would be ready to bring the biosimilar to th...
- Cancer drugs made by Emcure, Roche still expensive for patientsLast year, Swiss drug maker Roche, said it had signed a deal with Emcure Pharma to manufacture low-cost versions of its breast cancer drug.
- MSF welcomes India's decision to reject drug patent to Roche'Medicins Sans Frontieres', an international medical humanitarian group, today welcomed India's decision to reject a patent granted to Swis...
- Swiss co Roche loses patent on anti-viral drug ValcyteRoche, a Swiss drugmaker, lost the patent in India on its anti-viral drug Valcyte, widely used by AIDS patients, after the patent office co...
- Roche says half-year profit down 29 per centPharmaceuticals maker Roche Holding AG says net income was down 29 per cent for the first half after the takeover of Genentech.
- SC asks Roche not to pursue Cipla case until patent examinationThe Supreme Court (SC) has asked Swiss company Roche not to pursue the patent violation case against the generic version of Cipla’s anti-in...
- HC breather for Roche in Cipla caseRoche has received a breather with the Bombay High Court granting company's request for an injunction against Cipla.
- Roche sues Cipla over Valcyte patent breachSwiss major Roche has moved the Bombay High Court (HC) against domestic major Cipla for allegedly infringing both the patent and trademark ...
- Roche to force through Ventana mergerPharmaceuticals maker Roche Holding AG said on Tuesday it is poised to complete its acquisition of Ventana Medical Systems Inc.
Load More
